Insights into the therapeutic outcomes of trimetazidine/doxorubicin combination in Ehrlich solid-phase carcinoma mouse tumor model
Somaya M. Abdeljalil, Sara A. Wahdan, Hesham Elghazaly, Mai F. Tolba
Topics & Concepts
DoxorubicinIn vivoTrimetazidinePharmacologyAMPKCancer researchCancer cellChemistryApoptosisCancerProtein kinase AMedicineBiochemistryKinaseBiologyInternal medicineChemotherapyBiotechnologyCancer, Lipids, and MetabolismChemotherapy-induced cardiotoxicity and mitigationCancer, Hypoxia, and Metabolism